Capecitabine Production Cost Reports

The report provides a detailed analysis essential for establishing a capecitabine production plant. It encompasses all critical aspects necessary for capecitabine production, including the cost of capecitabine production, capecitabine plant cost, capecitabine production costs, and the overall capecitabine production plant cost. Additionally, the study covers specific expenditures associated with setting up and operating a capecitabine production plant. These encompass production processes, raw material requirements, utility requirements, infrastructure needs, machinery and technology requirements, manpower requirements, packaging requirements, transportation requirements, and more.

Capecitabine is an oral chemotherapy drug that targets various cancers with specific treatment roles. It is primarily utilised as an oral chemotherapy medicine for the treatment of various types of cancer, especially breast cancer, colorectal cancer, and gastric cancer. It finds its main application in cancer therapy, where it helps slow down or stop the growth of cancer cells in the body. It is often prescribed as part of combination treatment plans along with other anticancer drugs to improve effectiveness. It is also used in the treatment of advanced breast cancer when prior therapies like anthracyclines fail, as well as gastric, oesophageal, and gastroesophageal junction cancers in combination regimens. It is also used in advanced or metastatic cancer cases where patients require long-term cancer management with convenient oral dosing instead of injectable chemotherapy.

The demand for capecitabine is driven by its application as an orally-administered chemotherapeutic agent for the treatment of various types of cancers, which boosts its market expansion. Its application as an antineoplastic agent in managing colorectal cancer, breast cancer, and certain stomach cancers significantly fuels its demand in the oncology and medical sectors. Its application as a drug in combination with other cancer therapies to improve treatment effectiveness and patient outcomes further contributes to its demand in the medical and pharmaceutical industries. Its application in pancreatic cancer adjuvant therapy and in clinical trials for neoadjuvant rectal approaches also boosts its demand in the medical and pharmaceutical research industries.

Its demand as a medication in cancer treatment and supportive care, because it allows treatment through tablets rather than injections, also drives its demand in the modern oncology sector. Additionally, industrial capecitabine procurement depends on several factors such as the cost and supply of active pharmaceutical ingredients (APIs), adherence to stringent regulatory approvals, and compliance with quality and safety standards. Technological improvements in drug formulation, supplier capacity, consistent API quality, and robust logistics frameworks also play an important role in shaping its procurement processes globally.

Raw Material for Capecitabine Production

According to the capecitabine production plant project report, the major raw materials for capecitabine production include 2',3'-di-O-acetyl-5'-deoxy-5-fluoro-N4-(pentyloxycarbonyl)cytidine, sodium hydroxide solution, concentrated hydrochloric acid, dichloromethane, ethyl acetate, and n-hexane.

Production Process of Capecitabine

The extensive capecitabine production cost report consists of the following industrial production process:

1. Production via Chemical Synthesis: The production process of capecitabine begins with dissolving 2',3'-di-O-acetyl-5'-deoxy-5-fluoro-N4-(pentyloxycarbonyl)cytidine in methanol, followed by the slow addition of a sodium hydroxide solution under cold conditions to control the temperature. After the reaction, concentrated hydrochloric acid is carefully added to adjust the pH, and the mixture is then separated using dichloromethane and water. The organic layer is washed, dried, and the solvent is removed under reduced pressure. Then, the residue is dissolved in ethyl acetate, and n-hexane is added gradually to induce crystallisation. After a few hours at room temperature, the resulting crystals are filtered and washed to obtain capecitabine as the final product.

Capecitabine is an orally administered fluoropyrimidine carbamate that acts as an anticancer prodrug, enzymatically converted to 5-fluorouracil (5-FU) within tumour tissues. It appears as a white to almost white crystalline powder. The molecular formula of the compound is C15H22FN3O6, and its molar mass is 359.35 g/mol. It has a density of approximately 1.49 g/cm³, and has a melting point in the range of 110–121 degree Celsius. It is commercially marketed under the trade name Xeloda. The compound is soluble in water at approximately 26 mg/mL, freely soluble in ethanol at approximately 207 mg/mL, and also soluble in methanol, dimethylformamide (DMF), and dimethyl sulfoxide (DMSO). The flash point of the compound is 87 degree Celsius, and it is recommended to store the compound at 2–8 degree Celsius to maintain its stability. It is a known cytotoxic agent that may cause fetal harm when administered to pregnant women, and it is classified as harmful if swallowed. It is advised to wear protective clothing, gloves, and safety glasses while handling the compound. Extended or improper exposure to this substance may lead to serious adverse health effects, including myelosuppression, hand-foot syndrome, severe diarrhoea, and cardiotoxicity.